The ENT Devices Market Size was valued at USD 19.4 billion in 2022 and is projected to grow from USD 20.60 Billion in 2023 to USD 29.56 billion by 2030.
The ENT (Ear, Nose, and Throat) devices market is witnessing significant growth, driven by advancements in medical technology and an increasing prevalence of ENT-related disorders. ENT devices play a crucial role in the diagnosis and treatment of conditions affecting the ear, nose, and throat, ranging from hearing impairments to sinusitis and vocal cord disorders.
One key segment within the ENT devices market is ent surgical instruments, which are essential tools used by healthcare professionals during various ENT procedures. These instruments include but are not limited to forceps, scissors, specula, and otoscopes. Advancements in materials and design have led to the development of precision-engineered ENT surgical instruments, enhancing the efficiency and accuracy of surgical procedures.
Ent surgical equipment is another integral component of the ENT devices market, encompassing a broad range of devices used in surgical interventions. This category includes powered surgical tools, endoscopes, and imaging systems tailored for ENT procedures. The demand for minimally invasive surgeries has fueled the adoption of advanced ent surgical equipment, as these technologies offer reduced recovery times and improved patient outcomes.
The growing geriatric population, coupled with an increased awareness of ENT disorders, is contributing to the expansion of the global ENT devices market. Additionally, the rising prevalence of chronic conditions such as hearing loss and sinusitis is driving the demand for innovative and effective ENT solutions.
Segment Analysis
The global ENT devices market has been segmented by the experts of MRFR into product and end user. Factors and dynamics have been studied in detail to get a proper overview of these segments so that they can help in better assessment of strategies.
By product, the report on the global ENT devices market can be segmented into surgical devices, diagnostic devices, hearing implants, Co2 lasers, hearing aids, and image-guided surgery systems. The diagnostic devices segment includes endoscopes and hearing screening devices. The endoscopes segment comprises rigid endoscopes and flexible endoscopes. The rigid endoscope segment includes otoscopes and sinuscopes. The flexible endoscope segment has been segmented into laryngoscopes, pharyngoscopes, rhinoscopes, and nasopharyngoscopes. The surgical devices segment includes surgical instruments, handheld instruments, balloon sinus dilation devices, ear tubes, ENT supplies, radiofrequency (RF) handpieces, and voice prosthesis devices. The handheld instrument segment has been segmented into head and neck surgery instruments, otology instruments, laryngeal instruments, rhinology instruments, and others. The ENT supplies segment includes nasal stents, packing material, & splints.
By end-user, the study on the ENT devices market includes ambulatory settings, ENT clinics, hospitals, home care settings, research and academic institutes, and others. The hospitals and various ENT clinics are expected to create notable traction for the global market.
Major Key Players:
The global ENT Devices Companies are Cochlear Limited, Atos Medical AB, Karl Storz Gmbh & Co. Kg, Hoya Corporation, Johnson & Johnson Services, Inc., Olympus Corporation, Medtronic PLC, Siemens Healthcare, Rion Co. Ltd, Starkey Laboratories Inc., Widex A/S, William Demant Holding A/S, Stryker Corporation, Smith & Nephew PLC, Sonova Holding AG, and others. These companies are investing a lot in developing strategies that could withstand various adversities and ensure easy growth for the market. Their strategic moves often include various types of collaborations, mergers, hike in investment for better research and development, increasing innovation, various launching strategies, and others. MRFR’s inclusion of these moves in the report is to ensure a proper understanding of the market and help companies in developing strategies with a comprehensive overview.
Recent Development
October 2023: The US Food and Drug Administration (FDA) granted Galen Robotics authorization and a De Novo classification grant for the Galen ES Robotic System. With the authorization, the device may be marketed for application in rigid microlaryngeal procedures. The purpose of the novel surgical assist device powered cooperatively is to facilitate ear, nose, and throat (ENT) procedures. ENT surgical procedures, such as instrument implantation and the utilization of microlaryngeal alligator forceps, are within its scopes. The instrument is precisely and steadily positioned by the device in accordance with the surgeon's movements; the surgeon retains direct physical control over the instrument throughout. Additionally, Galen ES offers the possibility of instrument stability during critical microlaryngeal procedures. Its objective is to improve patient outcomes through the provision of sophisticated features and rapid setup time that augment the capabilities of otolaryngologists.
January 2023: EndoTheia Inc., a medical device company headquartered in the US, received a Breakthrough Device designation from the FDA in January 2023. This designation grants the company priority status with the FDA for its technology, which significantly enhances minimally invasive flexible endoscopic surgery. This designation has been bestowed upon only the seventh device in the category of Ear Nose and Throat (ENT) devices in history. The designation will facilitate the regulatory process, allowing EndoTheia to introduce its innovative solution to physicians and patients in a timely manner. This technological advancement utilizes laser-machined metallic tubes with exceptionally thin walls to fabricate steerable, highly flexible devices capable of traversing conventional endoscopes while simultaneously housing interventional instruments. The provision of steerability to endoscope-delivered instruments by these devices paves the way for novel therapeutic and diagnostic applications of flexible endoscopy.
Regional Analysis
The Americas have the scope to dominate the global market for ENT devices. The market is gaining from easy inclusion of latest technologies, smooth flow of investment, rise in production resulted from the increasing research and development activities, and several others. The US is showing a huge patient pool that can be a major tailwind provider for the global ENT devices market.
The Asia Pacific region is expected to profit from the rise in demand for advanced technologies from its huge population. Innovations and infrastructural changes are expected to influence regional market growth.
Browse Related Reports:
Artificial Intelligence in Drug Discovery Market
For More Information, Please Visit @ Market Research Future
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek